Skip to main content
SpringerLink
Log in

Control of epidemic influenza virus: aspects of vaccines and antiviral compounds

  • Chapter
IUPHAR 9th International Congress of Pharmacology London 1984

  • 145 Accesses

Abstract

The earth is a unity for influenza A virus in a manner not yet found for any other parasite (Hope-Simpson 1979). Epidemics occur in all inhabited parts of the globe regardless of latitude, longitude, altitude climate, rainfall, temperature, humidity, race and sex (Stuart-Harris & Schild 1976; Pereira 1979 Stuart-Harris 1981). Influenza A is the classic pandemic virus infection of humans, but influenza B virus can also cause sharp outbreaks resulting in significant mortality. Mortality data from 1200 million people living in 88 of the 160 or so WHO member states (approximately one quarter of the world’s population) show that more than two million deaths from acute respiratory disease occur annually (reviewed by Lennette, 1981, see also Table 1) and that the majority of acute viral respiratory disease is attributed to viruses of 5 families. Influenza A and B viruses cause a significant number of these deaths.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • ALEXANDROVA, G.I. & SMORODINTSEV, A.A. (1965). Obtaining of an additionally attenuated vaccinating cryophilic influenza strain. Rev. Roum. Inframicrobiol., 2, 179–186.

    Google Scholar 

  • ALLING, D.W., BLACKWELDER, W.C. & STUARTHARRIS, C.H. (1981). A study of excess mortality during influenza epidemics in the United States 1968–1976. Am. J. Epidemiol., 113, 30–43.

    Google Scholar 

  • AOKI, F.Y., SITAR, D.S. & OGILVIE, R.I. (1979). Amantadine kinetics in healthy young subjects after long-term dosing. Clin. Pharmac. Ther., 6, 729–736.

    Google Scholar 

  • BEARE, A.S. (1982). (ed.) Basic and Applied Influenza Research, Cleveland, Ohio: CRC Press.

    Google Scholar 

  • BLAAS, D., PATZELT, E. & KUECHLER, E. (1982). Cap recognizing protein of influenza virus. Virology, 116, 339–348.

    Google Scholar 

  • BLEIDNER, W.E., HARMON, J.B., NEWES, W.E., LYNES, T.E. & HERMANN, E.C. (1965). Absorption, distribution, and excretion of amantadine hydrochloride. J. Pharmac. exp. Ther., 150, 484–490.

    Google Scholar 

  • BUKRINSKAYA, A.G., VORKUNOVA, N.K. & NARMANBETOVA, R.A. (1980). Rimantadine hydrochloride blocks the second step of influenza virus uncoating. Arch. Virol., 66, 275–282.

    Google Scholar 

  • CENTERS FOR DISEASE CONTROL (1982). Influenza vaccine efficacy in nursing home outbreaks reported during 1981–1982. MMWR, 31, 190.

    Google Scholar 

  • CHANOCK, R.M. (1982). New Opportunities for development of safe effective live virus vaccines. Yale J. biol. Med., 55, 361–367.

    PubMed  CAS  PubMed Central  Google Scholar 

  • CHRETIEN, J., HOLLAND, W., MACKLEM, P., MURRAY, J. & WOOLCOCK, A. (1984). Acute respiratory infections in children: a global health problem. N. Engl. J. Med., 982–984.

    Google Scholar 

  • CLOAD, P.A. & HUTCHINSON, D.W. (1983). The inhibition of the RNA polymerase activity of influenza virus A by pyrophosphate analogues. Nucl. Acid. Res., 11, 5621–5628.

    Google Scholar 

  • DAVIES, W.L., GRUNERT, R.R., HAFF, R.F., McGAHEN, J.W., NEUMAYER, E.M., PAULSHOCK, M. & 4 OTHERS (1964). Science, 144, 862–863.

    Google Scholar 

  • DOLIN, R., REICHMAN, R.C., MADORE, H.P., MAYNARD, R., LINTON, P.M. & WEBBER-JONES, J. (1982). A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection. New. Engl. J. Med., 307, 580–584.

    Google Scholar 

  • DOLIN, R., BETTS, R.F., TREENER, J.J., ERB, S.M., O’BRIEN, D.H., ROTH, F.K., MILLER, P., DUFFY, P. (1983). Rimantadine prophylaxis of influenza A in elderly. Proceedings of the23rd ICAAC, October 1983, Abstract no.691, p.210.

    Google Scholar 

  • DOUGLAS, R.G., Jr (1980). Amantadine: Should it be used as an antiviral? In Controversies in therapeutics, Lasagna, L. (ed.) pp.271–280, Philadelphia: W.-B. Saunders.

    Google Scholar 

  • EATON, M.D., LOW, I.E., SCALA, A.R. & URETSKY, S. (1962). Inhibition by ammonium ion of the growth of influenza virus in chorio allantoic tissue. Virology, 118, 102–108.

    Google Scholar 

  • EMTAGE, J.S., TACON, W.C.A., CATLIN, G.H., JENKINS, B., POSTER, A.G. & CAREY, N.H. (1980). Influenza antigenic determinants are expressed from haemagglutinin genes cloned in E. coli. Nature, 283, 171–174.

    Google Scholar 

  • FIELDS, S., WINTER, G. & BROWNLEE, G.G. (1981). Structure of the neuraminidase gene in human influenza virus A/PR/8/34. Nature, 290, 213.

    Google Scholar 

  • GALBRAITH, A.W., OXFORD, J.S., SCHILD, G.C. & WATSON, G.I. (1969). Protective effect of 1-adamantamine hydrochloride on influenza A2 infections in the family environment. Lancet, 1026–1028.

    Google Scholar 

  • GALASSO, G.J., BEKTIMIROV, T.A., DOUGLAS, R.G., KRYLOV, V.F. & OXFORD, J.S. (1984). Current status of amantadine and rimantadine as anti influenza agents: memorandum of a WHO meeting. Bull. Wld Hlth Org. (in press).

    Google Scholar 

  • GETHING, M.J. & SAMBROOK, J. (1982). Construction of influenza haemagglutinin genes that code for intracellular and secreted forms of the protein. Nature, 300, 598–603.

    Google Scholar 

  • GOODMAN, R.A., ORENSTEIN, W.A., MUNRO, T.F., SMITH, S.C. & SIKES, R.K. (1982). Impact of influenza A in a nursing home. J. Am. med. Ass., 247, 1451–1453.

    Google Scholar 

  • GREEN, N., ALEXANDER, H., OLSON, A., ALEXANDER, S., SHINNICK, T.M., SUTCLIFFE, J.G. & LERNER, R.A. (1982). Immunogenic structure of the influenza virus haemagglutinin. Cell, 28, 477–487.

    Google Scholar 

  • GRUNERT, R.R., McGAHAN, J.W. & DAVIES, W.L. (1965). The in vivo antiviral activity of 1-adamantanamine (amantadine). 1. Prophylactic and therapeutic activity against influenza viruses. Virology, 26, 262–269.

    Google Scholar 

  • HAYDEN, F.G., COTE, K.M. & DOUGLAS, R.G. (1980). Plaque inhibition assay for drug susceptibility testing of influenza viruses. Antimicrob. Ag. Chemo., 17, 865–870.

    Google Scholar 

  • HAYDEN, F.G., HOFFMAN, H.E. & SPYKER, D.A. (1983). Differences in side effects of amantadine hydrochloride and rimantadine hydrochloride relate to differences in pharmacokinetics. Antimicrob. Ag. Chemo., 23, 458–464.

    Google Scholar 

  • HEIDER, H., ADAMCZCK, B., PRTESBER, H.W., SCHROEDER, C., FELDBLUM, R. & INDULEN, M.K. (1981). Occurrence of amantadine and rimantadine resistant influenza A virus strains during the 1980 epidemic. Acta. Virol., 25, 395–400.

    Google Scholar 

  • HELGSTRAND, E. & OBERG, B.O. (1978). Antiviral screening based on cell-free polymerase models and a new selective inhibitor. Current Chemotherapy.

    Google Scholar 

  • HO, P.P.K. & WALTERS, C.P. (1971). Inhibitors of influenza virus induced RNA polymerase. Ann. N.Y. Acad. Sci., 133, 438.

    Google Scholar 

  • HOFFMAN, C.E. (1980). Amantadine HCl and related compounds. In Carter, W.A. (ed.) Selective inhibitors of viral functions, pp. 199–211, Cleveland, Ohio: CRC Press.

    Google Scholar 

  • HOPE-SIMPSON, R.E. (1979). Epidemic mechanisms of Type A influenza. J. Hyg., 83, 11–26.

    Google Scholar 

  • HORNICK, R.B., TOGO, Y., MAHLER, S. & IEZZONI, D.G. (1970). Evaluation of amantadine hydrochloride in the treatment of A2 influenzal disease. Ann. N.Y. Acad. Sci., 173 (1), 10–19.

    Google Scholar 

  • INDULEN, M.K. & KALNINYA, V.A. (1980). Studies on the Antiviral effect and the mode of action of the anti-influenza compound rimantadine. In Development in Antiviral Therapy, Collier, L.H. & Oxford, J.S. (eds) pp. 107–118, London: Academic Press.

    Google Scholar 

  • JACKSON, G.C., MULDOON, R.L. & AKERS, L.W. (1963). Serological evidence for prevention of influenzal infection in volunteers by an anti-influenzal drug adamantanamine hydrochloride. Antimicrob. Ag. Chemo., 703–707.

    Google Scholar 

  • KILBOURNE, E.D. (1969). Future influenza vaccines and the use of genetic recombinants. Bull. Wld Hlth Org., 41, 643–645.

    CAS  Google Scholar 

  • KNIGHT, V., McCLUNG, H.W., WILSON, S.Z. et al. (1981). Ribavirin small-particle aerosol treatment of influenza. Lancet, ii, 945–949.

    Google Scholar 

  • LENNETTE, E.M. (1981). Viral respiratory diseases: Vaccines and antivirals. Bull. Wld. Hlth. Org., 59, 305–324.

    CAS  Google Scholar 

  • MAEDA, T., KAWASAKI, K. & OHNISHI, S.-I. (1981). Interaction of influenza virus haemagglutinin with target membrane lipids is a key step in virus-induced hemolysis and fusion at pH 5.2 Proc. natn. Acad. Sci. U.S.A., 78, 4133.

    Google Scholar 

  • MAASSAB, H.F. (1967). Adaptation and growth characteristics of influenza virus at 25°C. Nature, 213, 612–614.

    Article  PubMed  CAS  Google Scholar 

  • McCLUNG, H.W., KNIGHT, V., GILBERT, B.E., WILSON, S.Z., QUARLES, J.M. & DIVINE, ?. (1983). Ribavirin aerosol treatment of influenza B virus infection. J. Am. med. Ass., 249, 2671–2674.

    Google Scholar 

  • MCCAULEY, J.W. & MAHY, B.W.J. (1983). Structure and function of the influenza virus genome. Biochem. J., 211, 281.

    Google Scholar 

  • MONTO, A.S., GUNN, R.A., BANDYK, M.G. & KING, C. (1979). Prevention of Russian Influenza by Amantadine. J.Am.med.Ass., 241, 1003–1007.

    Google Scholar 

  • NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES. (1980). Amantadine: does it have a role in the prevention and treatment of influenza A. A National Institutes of Health Consensus Development Conference. Ann. Intern. Med., 92, 256–258.

    Google Scholar 

  • OXFORD, J.S. (1975). Inhibition of the replication of influenza A and B viruses by a nucleoside analogue (ribavirin). J. gen. Virol., 28, 409–414.

    Article  PubMed  CAS  Google Scholar 

  • OXFORD, J.S. (1983). Amantadine — problems with its clinical usage. In Problems of antiviral chemotherapy. Stuart-Harris, C.H. & Oxford, J.S. (eds.) p. 231, London: Academic Press.

    Google Scholar 

  • OXFORD, J.S. & GALBRAITH, A. (1980). Antiviral activity of amantadine: a review of laboratory and clinical data. Pharmac. Rev., 11, 181–262.

    Google Scholar 

  • OXFORD, J.S., HAAHEIM, L.R., SLEPUSHKIN, A., WERNER, J., KUWERT, E. & SCHILD, G.C. (1981). Strain specificity of serum antibody to the haemagglutinin of influenza A (H3N2) viruses in children following immunization or natural infection. J. Hyg. Camb., 86, 17.

    Google Scholar 

  • OXFORD, J., LOGAN, I.S. & POTTER, C.W. (1970). In vivo selection of an influenza A 2-strain resistant to amantadine. Nature, 226, 82–83.

    Google Scholar 

  • OXFORD, J.S., McGEOCH, D.J., SCHILD, G.C. & BEARE, A.S. (198(. Analysis of virion RNA segments and polypeptides of influenza A virus recombinants of defined virulence. Nature, 273, 778–779.

    Google Scholar 

  • OXFORD, J.S. & PERRIN, D.D. (1974). Inhibition of the particle associated RNA dependent RNA polymerase activity of influenza viruses by chelating agents. J. gen. Virol., 23, 59.

    Google Scholar 

  • PATRIARCA, P.A., KATER, N.A., KENDAL, A.P., BREGMAN, D.J., SMITH, J.D. & SIKES, R.K. (1983). Safety of prolonged administration of rimantadine hydrochloride in the prophylaxis of influenza A infections in nursing homes. Interscience Conference on Antimicrobial Agents and Chemotherapy, Las Vegas, Nevada, October 1983.

    Google Scholar 

  • PALESE, P. & SCHULMAN, J.L. (1977). Inhibitors of viral neuraminidase as potential antiviral drugs. In Chemoprophylaxis and Virus Infections of the Respiratory Tract, vol. I, p. 689 Oxford, J.S. (ed.) Cleveland, Ohio: CRC Press.

    Google Scholar 

  • PAYLER, D.K. & PURDHAM, P.A. (1984). Influenza A prophylaxis with amantadine in a boarding school. Lancet, i, 502–504.

    Google Scholar 

  • PEREIRA, M.S. (1979). Global surveillance of influenza. Br. med. Bull., 35, 9–14.

    PubMed  CAS  Google Scholar 

  • PERRIN, D.D. (1977). In Chemoprophylaxis and Virus Infections of the Respiratory Tract vol. II. Oxford, J.S. (ed.) Cleveland, Ohio: CRC Press.

    Google Scholar 

  • PERRIN, D.D. & STUNZI, H. (1980). Viral chemotherapy: antiviral actions of metal ions and metal chelating agents. Pharmac. Ther., 12, 255–297.

    Google Scholar 

  • POTTER, C.W., PHAIR, J.P., VODINELICH, L., FENTON, R. & JENNINGS, R. (1976). Antiviral, immunosuppressive and anti-tumour effects of ribavirin. Nature, 259, 496–497.

    Google Scholar 

  • RICHARDSON, C.D., SCHEID, A. & CHOPPIN, P.W. (1980). Specific inhibition of paramyxovirus and Myxovirus replication by oligopeptides with amino acid sequences similar to those at the N-termini of the Fl or HA2 viral polypeptides. Virology, 105, 205–222.

    Google Scholar 

  • RICHMAN, D.D. & MURPHY, B.R. (1979). The association of the temperature sensitive phenotype with viral attenuation in animals and humans: implication for the development and use of live virus vaccines. Rev. Infect. Dis., 1, 413–473.

    Google Scholar 

  • RICHMAN, D.D., YAZAKI, P. & HOSTETLER, K.Y. (1981). The intracellular distribution and antiviral activity of amantadine. Virology, 112, 81–90.

    Google Scholar 

  • SCHILD, G.C., OXFORD, J.S., JONG, J. DE. & WEBSTER, R.G. (1983). Evidence for host cell selection of antigenic variants of influenza B virus. Nature, 303, 706–709.

    Google Scholar 

  • SCHULMAN, J.L. & KILBOURNE, E.D. (1965). Induction of partial specific heterotypic immunity in mice by a single infection with influenza A virus. J. Bact., 89, 170–174.

    Google Scholar 

  • SCHWAB, R.S., POSKANZER, D.C., ENDLAND, A.C. & YOUNG, R.R. (1972). Amantadine in Parkinson’s disease — review of more than two years’ experience. J. Am. med. Ass., 222, 792–795.

    Google Scholar 

  • SELBY, P. (ed.) (1976). Influenza: virus, vaccines and strategy. New York: Academic Press.

    Google Scholar 

  • SIDWELL, R.W., HUFFMAN, J.H., KHARE, G.P., ALLEN. L.B., WITKOWSKI, J.T. & ROBINS, R.K. (1972). Broadspectrum antiviral activity of Virazole: 1-B-Dribofuranosyl-1,2,4-triazole-3-carboxamide. Science, 177, 705–706.

    Google Scholar 

  • SMITH, R.A. & KIRKPATRIC, W. (eds.) (1980). Ribavirin: a broad spectrum antiviral agent, pp. 59–71, New York: Academic Press.

    Google Scholar 

  • STRIDH, S., HELGSTRAND, E., LANNEROE, B., MISIORNY, A., STENING, G. & OBERG, B. (1979). The effect of pyrophosphate analogues on influenza virus RNA polymerase and influenza virus replication. Arch. Virol., 61, 245–250.

    Google Scholar 

  • STUART-HARRIS, C.H. (1981). The epidemiology and prevention of influenza. Am. Scient., 69, 166–172. STUART-HARRIS, C.H. & SCHILD, G.C. (1976) In Influenza, the virus and the Disease, London: Edward Arnold.

    Google Scholar 

  • SWALLOW, D.L. (1978). Antiviral agents. Progr. Drug. Res., 22, 267–326.

    CAS  Google Scholar 

  • TILLETT, H.E., SMITH, J.W.G. & CLIFFORD, R.E. (1980). Excess morbidity and mortality associated with influenza in England and Wales. Lancet, i, 793–795.

    Google Scholar 

  • VARGHESE, J.N., LAVER, W.G. & COLMAN, P.M. (1983). Structure of the influenza virus glycoprotein antigen neuraminidase at 2–9 A resolution. Nature, 303, 35.

    Google Scholar 

  • VAN VORIS, L.P., BETTS, R.F., HAYDEN, F.G., CHRISTMAS, W.A. & DOUGLAS, R.G., JR. (1981). Successful treatment of naturally occurring influenza A/USSR/77 HINI. J. Am. med. Ass., 245, 1128–1131.

    Google Scholar 

  • WEBSTER, R.G., LAVER, W.G., AIR, G.M. & SCHILD, G.C. (1982). Molecular mechanisms of variation in influenza viruses. Nature, 296, 115.

    Google Scholar 

  • WERNER, G.H. (1966). ImmunitĂ© croisĂ©e HĂ©tĂ©rotypique chez la souris entrevirus grippaux humains de types A et A2. C.R. Acad. Paris, 263, 1913–1916.

    CAS  Google Scholar 

  • WHITE, J., KARTENBECK, J. & HELENIUS, A. (1982). Membrane fusion activity of influenza virus, EMBO Journal, 1, 217.

    Google Scholar 

  • WORLD HEALTH ORGANISATION (1984). A programme for controlling acute respiratory infections in children: memorandum from a WHO meeting. Bull. Wld. Hlth. Org., 62, 47–58.

    Google Scholar 

  • WILEY, D.C., WILSON, I.A. & SKEHEL, J.J. (1981). Structural identification of the antibody binding sites of the Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature, 298, 373.

    Google Scholar 

  • WILSON, I.A., SKEHEL, J.J. & WILEY, D.C. (1981). The haemagglutinin membrane glycoprotein of influenza virus: structure at 3 A resolution. Nature, 289, 366.

    Google Scholar 

  • YOUNKIN, S.W., BETTS, R.F., ROGH, F.K. & DOUGLAS, R.G., JR. (1983). Reduction in fever and symptoms in young adults with Influenza A/Brazil/78 HINI infection after treatment with aspirin or amantadine. Antimicrob. Ag. Chemo., 23, 577–582.

    Google Scholar 

  • ZLYDNIKOV, D.M., KUBAR, O.I., KOVALEVA, R.P. & KAMFORIN, L.E. (1981). Study of rimantadine in the USSR: a review of the literature. Rev. Inf. Dis., 3, 408–421.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Virology, National Institute for Biological Standards and Control, Holly Hill, Hampstead, London, NW36RB, UK

    J. S. Oxford

Authors
  1. J. S. Oxford
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

William Paton James Mitchell Paul Turner

Copyright information

© 1984 Macmillan Publishers Limited

About this chapter

Cite this chapter

Oxford, J.S. (1984). Control of epidemic influenza virus: aspects of vaccines and antiviral compounds. In: Paton, W., Mitchell, J., Turner, P. (eds) IUPHAR 9th International Congress of Pharmacology London 1984. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-17613-7_38

Download citation

Publish with us

Policies and ethics

Search

Navigation